Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ; APRICOT Investigators. Rodríguez-Torres M, et al. Among authors: brau n. J Med Virol. 2007 Jun;79(6):694-700. doi: 10.1002/jmv.20836. J Med Virol. 2007. PMID: 17457912
Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status.
Lo Re V 3rd, Newcomb CW, Carbonari DM, Mezochow AK, Hennessy S, Rentsch CT, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa C, Njei B, Roy JA, Taddei TH, Justice AC, Torgersen J. Lo Re V 3rd, et al. Among authors: brau n. Pharmacoepidemiol Drug Saf. 2024 Dec;33(12):e70069. doi: 10.1002/pds.70069. Pharmacoepidemiol Drug Saf. 2024. PMID: 39662972 Free PMC article.
Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data.
Torgersen J, Mezochow AK, Newcomb CW, Carbonari DM, Hennessy S, Rentsch CT, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa C, Njei B, Roy JA, Taddei TH, Justice AC, Lo Re V 3rd. Torgersen J, et al. Among authors: brau n. JAMA Intern Med. 2024 Aug 1;184(8):943-952. doi: 10.1001/jamainternmed.2024.1836. JAMA Intern Med. 2024. PMID: 38913369 Free PMC article.
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma.
Pinato DJ, Kaneko T, D'Alessio A, Forner A, Fessas P, Minguez B, Giannini EG, Grillo F, Díaz A, Mauri FA, Fulgenzi CAM, Dalla Pria A, Goldin RD, Pieri G, Toniutto P, Avellini C, Plaz Torres MC, Akarca AU, Marafioti T, Bhoori S, Miró JM, Bower M, Bräu N, Mazzaferro V. Pinato DJ, et al. Among authors: brau n. JHEP Rep. 2023 Mar 22;5(7):100741. doi: 10.1016/j.jhepr.2023.100741. eCollection 2023 Jul. JHEP Rep. 2023. PMID: 37274775 Free PMC article.
A Learning Health System Approach to Long COVID Care.
Gustavson AM, Purnell A, Adly M, Awan O, Bräu N, Braus NA, Bryant MS, Chang L, Cyborski C, Darvish B, Del Piero LB, Eaton TL, Kiliveros A, Kloth H, McNiel ER, Miller MA, Patrick A, Powers P, Pyne M, Rodriguez IG, Romesser J, Rud B, Seidel I, Tepper A, Trinh H, Tonkin B, Vachachira J, Yang H, Shak JR. Gustavson AM, et al. Among authors: brau n. Fed Pract. 2022 Jul;39(7):310-314. doi: 10.12788/fp.0288. Epub 2022 Jul 11. Fed Pract. 2022. PMID: 36425345 Free PMC article.
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA).
Rosas IO, Bräu N, Waters M, Go RC, Malhotra A, Hunter BD, Bhagani S, Skiest D, Savic S, Douglas IS, Garcia-Diaz J, Aziz MS, Cooper N, Youngstein T, Sorbo LD, Zerda DJ, Ustianowski A, Gracian AC, Blyth KG, Carratalà J, François B, Benfield T, Haslem D, Bonfanti P, van der Leest CH, Rohatgi N, Wiese L, Luyt CE, Bauer RN, Cai F, Lee IT, Matharu B, Metcalf L, Wildum S, Graham E, Tsai L, Bao M. Rosas IO, et al. Among authors: brau n. EClinicalMedicine. 2022 May;47:101409. doi: 10.1016/j.eclinm.2022.101409. Epub 2022 Apr 21. EClinicalMedicine. 2022. PMID: 35475258 Free PMC article.
Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation.
Torgersen J, Newcomb CW, Carbonari DM, Rentsch CT, Park LS, Mezochow A, Mehta RL, Buchwalder L, Tate JP, Bräu N, Bhattacharya D, Lim JK, Taddei TH, Justice AC, Lo Re V 3rd. Torgersen J, et al. Among authors: brau n. J Hepatol. 2021 Dec;75(6):1312-1322. doi: 10.1016/j.jhep.2021.07.021. Epub 2021 Jul 29. J Hepatol. 2021. PMID: 34333102 Free PMC article.
88 results